Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Progyny Q2 2024 Adj EPS $0.43 Beats $0.17 Estimate, Sales $304.09M Miss $305.42M Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:08pm
Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.17 by 152.94 percent. The company reported quarterly sales of $304.09 million which missed the analyst consensus estimate of $305.42 million by 0.44 percent. This is a 8.85 percent increase over sales of $279.37 million the same period last year.

Posted In: PGNY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist